Overview

Thyroid Eye Disease (TED) or Graves' orbitopathy is an autoimmune disease affecting the eyes, often associated with thyroid disease, particularly hyperthyroidism caused by Graves' disease. TED can cause inflammation, swelling, or even vision loss. Early diagnosis and proper thyroid function control are critical in preventing disease progression and preserving the eyes. The sooner TED is diagnosed and treated, the better the chance there is to improve its influence and prevent long-term implications.

Thyroid eye disease recognition

Definition and pathophysiology

TED is an autoimmune condition where the immune system mistakenly destroys tissues around the eyes. This initiates inflammation, swelling, and tissue remodelling that leads to bulging eyes (proptosis), double vision (diplopia), and, in advanced cases, vision loss from compression of the optic nerve. The condition occurs with inflammatory as well as degenerative changes, leading to a range of signs and complications that worsen with time unless treated.¹

Causes and risk factors

The principal aetiology of TED is Graves' disease, which is an autoimmune thyroid disease causing hyperproduction of thyroid hormones.¹ TED is also observed in hypothyroidism or euthyroid patients. The risk factors include genetic susceptibility, smoking, female gender, elevated thyroid-stimulating immunoglobulin (TSI), and environmental exposure. Smoking is also an important risk factor and has been identified to markedly increase the prevalence as well as the severity of TED by increasing the inflammatory process ²

Common symptoms and steps of progression

TED symptoms range from mild to severe and typically progress through two stages:

• Active phase – It is marked by inflammation, redness, swelling, and pain. This phase may last anywhere from six months to three years, during which treatment focuses on reducing inflammation and preventing permanent damage³
• Chronic phase – There is fibrosis and scarring of tissues, which lead to permanent changes such as bulging eyes and double vision. Treatment becomes more limited once the chronic stage begins, with surgery often being required to correct structural faults³

Importance of early diagnosis

Early symptoms of TED

The early signs of TED include eye irritation, dryness, watery discharge, light sensitivity, swelling of the eyelids, and grittiness in the eyes. As the condition progresses, it becomes evident with bulging eyes, inability to close the eyelids, and loss of vision. Some patients will experience pressure in the back of the eyes, feeling tightness, or inability to move the eyes in certain directions.³

Diagnostic techniques

• Clinical examination – An ophthalmologist assesses the movement of the eyes, position of the eyelids, and overall ocular health and identifies typical presentations of TED, such as lid retraction and proptosis⁴
• Imaging tests – MRI, CT, or orbital ultrasonography views inflammation and changes in tissues to support differential diagnosis⁴
• Blood tests – TSH, T3, T4 thyroid hormone levels, and thyroid antibodies (TRAb) obtained can confirm thyroid dysfunction, thus supporting both the diagnosis and therapy of TED⁴

Differentiation of TED from other eye diseases

TED should be differentiated from other ocular disorders like orbital cellulitis, idiopathic orbital inflammatory disease, or myasthenia gravis, which will have different modalities of management despite similar signs and symptoms. A thorough assessment must be done by both an ophthalmologist and an endocrinologist to accurately diagnose and develop a treatment plan.

Control of thyroid function in the prevention of TED

Sustaining euthyroid state

Consistent thyroid hormone levels decrease the likelihood of TED worsening. Both hyperthyroidism and hypothyroidism are likely to worsen the condition. Effective management of thyroid function can have a great impact on the severity and course of TED.

Treatment methods for thyroid dysfunction

• Antithyroid Drugs – Medications such as methimazole and propylthiouracil regulate excessive thyroid function, inhibiting further immune stimulation that can worsen TED⁵
• Radioactive Iodine Therapy (RAI) – The most widely used hyperthyroidism therapy, but it may exacerbate TED in some cases. Steroid prophylaxis can be given to high-risk patients for the exacerbation of TED before RAI therapy⁵
• Thyroidectomy – Thyroid removal operation is a consideration in patients who have severe hyperthyroidism or contraindication for other modalities. This typically should be considered if medical treatment is not effective or in situations of urgent thyroid control⁵

Effect of untreated thyroid levels on the course of eye disease

Intermittent fluctuations in thyroid hormone levels may enhance inflammation and increase eye symptoms. Stable thyroid status is important in minimising TED severity. Inadequately controlled thyroid disease puts patients at increased risk of severe TED symptomatology and its complications.⁶

Other preventive measures

Lifestyle and environmental factors

• Smoking cessation – Smoking increases the risk and severity of TED significantly. Stopping smoking would retard disease progression and improve therapy outcomes
• Managing stress and autoimmune triggers – Stress reduction through meditation, a healthy diet, and sound sleep can modulate immune function. Stress augments autoimmune diseases such as TED⁷

Anti-inflammatory and immunomodulatory therapies

• Corticosteroids – Applied to reduce inflammation in advanced TED to avoid irreversible damage^5,6
• Biologic Therapies (e.g., Teprotumumab) – A monoclonal antibody specifically approved for TED that directly targets the insulin-like growth factor-1 receptor (IGF-1R), reducing inflammation and proptosis^5,6

Regular eye exams and progression monitoring

Ocular monitoring at frequent intervals ensures the detection of alterations in a timely fashion, such that intervention can be instituted before progression to severe complications. Routine endocrinologist follow-up is also required in maximising control of thyroid function.

Treatment choices for progressive conditions

Orbital decompression surgery

For extreme proptosis or optic nerve compression, orbital bone tissue is removed to create space for the inflamed tissues and relieve pressure. This can improve both function and appearance.³

Strabismus and eyelid surgery

In long-standing double vision or eyelid retraction, corrective surgery adjusts the alignment and function of the eyelids. Surgery is typically performed after TED stabilises in its chronic phase.³

Supportive therapies

Eye drops that lubricate, prisms to alleviate double vision, and colored lenses reduce pain and improve the quality of life in TED patients. Prompt use of artificial tears and moisture chamber glasses may be highly effective in alleviating symptoms.³

FAQs

How long does TED last?

TED usually progresses through an "active phase" (lasting 6 months to 2 years) followed by a "stable phase." In the active phase, inflammation is at its worst.

Can TED recur after treatment?

Once TED enters the stable phase, it usually does not reactivate. However, in some cases, symptoms can worsen, especially if thyroid levels fluctuate or the person smokes.

Is there a cure for TED?

There is no permanent cure, but treatments can effectively manage symptoms and prevent complications. Early intervention improves outcomes.

Can TED occur without thyroid disease?

Yes, but it is rare. Some people develop TED without thyroid dysfunction, though most cases are linked to Graves’ disease.

Conclusion

TED is a detrimental disorder, but timely diagnosis and proper thyroid management can significantly alter the course of progression. Regular screening, vigorous planning for thyroid functional stabilisation, and changes in life patterns will avert disastrous results. Continued research persists in offering new insights into promising therapies, holding promise for improved patient outcomes in the future. Patients can improve their quality of life while also reducing the burden of TED by identifying risk factors, requesting early care, and adhering to treatment schedules.